About AOA
AOA is a company based in Boston (United States) founded in 2019 by Alex Fisher, Anna Milik Jeter, and Oriana Papin Zoghbi. AOA has raised $40.67 million across 7 funding rounds from investors including Tencent, LabCorp and Good Growth Capital. The company has 23 employees as of December 31, 2024. AOA offers products and services including GlycoLocate and AKRIVIS GD. AOA operates in a competitive market with competitors including Aspira Women's Health, GenoME Diagnostics, KOKO Medical, VOC Diagnostics and Avant Diagnostics, among others.
- Headquarter Boston, United States
- Employees 23 as on 31 Dec, 2024
- Founders Alex Fisher, Anna Milik Jeter, Oriana Papin Zoghbi
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aoa Dx, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$40.67 M (USD)
in 7 rounds
-
Latest Funding Round
$8.09 M (USD), Series A
Oct 01, 2025
-
Investors
Tencent
& 24 more
-
Employee Count
23
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AOA
AOA offers a comprehensive portfolio of products and services, including GlycoLocate and AKRIVIS GD.
AI-enabled multi-omics platform for early cancer detection.
AI-based blood test for detecting early-stage ovarian cancer.
People of AOA
Unlock access to complete
Unlock access to complete
Funding Insights of AOA
AOA has successfully raised a total of $40.67M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $8.09 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in AOA
AOA has secured backing from 25 investors, including venture fund and institutional investors. Prominent investors backing the company include Tencent, LabCorp and Good Growth Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are focused on reproductive healthcare startups by Rhia Ventures.
|
Locked | Locked | Locked | |
|
Early-stage startups are accelerated via funding and educational programs.
|
Locked | Locked | Locked | |
|
Early-stage investments are made in life sciences and technologies.
|
Locked | Locked | Locked |
Investor details for AOA
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AOA
Investment portfolio details for AOA
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AOA
Detailed financials for AOA
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aoa Comparisons
Peer comparison for AOA
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AOA
AOA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aspira Women's Health, GenoME Diagnostics, KOKO Medical, VOC Diagnostics and Avant Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Diagnostic solutions for ovarian cancer risk in women are provided.
|
|
| Locked | Locked | Locked |
An in-vitro diagnostic test for ovarian cancer is developed.
|
|
| Locked | Locked | Locked |
Postpartum hemorrhage addressed by catheter-based medical device for women.
|
|
| Locked | Locked | Locked |
Developer of diagnostic solutions to detect ovarian cancer
|
|
| Locked | Locked | Locked |
Microarray technology is utilized for early ovarian cancer detection.
|
Detailed competitors of AOA
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aoa
Complete news archive for AOA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AOA
AOA was founded in 2019 and raised its 1st funding round 2 years after it was founded.
AOA is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Oriana Papin Zoghbi is the current CEO of AOA. They have also founded this company.
AOA is a funded company, having raised a total of $40.67M across 7 funding rounds to date.
As of Dec 31, 2024, the latest employee count at AOA is 23.
AOA, led by Alex Fisher as Co-Founder COO, Anna Milik Jeter as Co-Founder, Oriana Papin Zoghbi as Co-Founder CEO, specializes in life sciences, oncology, in-vitro diagnostic tests, womens cancer, and ovarian cancer. Provider of business consultancy services for biopharma industry. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction.
AOA's top competitors include Aspira Women's Health, KOKO Medical and GenoME Diagnostics.
AOA offers GlycoLocate and AKRIVIS GD.
AOA has 25 investors. Key investors include Tencent, LabCorp, Good Growth Capital, Rhia Ventures, and Y Combinator.